Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Phase: PHASE2 | Sponsor: Centre for Addiction and Mental Health | Compound: Psychedelic
- Status
- recruiting
- Institution
- Centre for Addiction and Mental Health
- Start date
- 2025-04-21
- End date
- 2027-09-01
- Registry ID
- NCT06512220
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.